key: cord-0902731-z4fy5dla authors: Thakur, Yamini; Pande, Rama title: Exploration of In-silico Screening of Therapeutic Agents Against SARS-CoV-2 date: 2021-09-04 journal: Chem Phys DOI: 10.1016/j.chemphys.2021.111354 sha: afbacddfa29f89e80b383ba0a4a8171056ba923c doc_id: 902731 cord_uid: z4fy5dla In the present investigation, molecular docking studies have been performed using AutoDock Vina to investigate the role of ligand-binding affinity at the hydrophobic pocket of COVID-19. The knowledge of the binding of protein receptors with ligand molecules is essential in drug discovery processes. Hydroxamic acids with reported biological activity, have been investigated for docking to an important target, SARS-CoV-2, in order to predict their therapeutic efficacy. The spike protein of the coronavirus is responsible for the attachment to host cells and a positive-sense single-strand RNA, (+)ssRNA, is a genetic material that can be translated into protein in the host cell. We modeled the structure of SARS-CoV-2 with the ligands, hydroxamic acids. They show binding capability with both, Spike protein and (+)ssRNA. The twain exhibit negative binding energies which signify that reactions are spontaneous, strong, and fast. The present research proposed hydroxamic acids as molecules which can be used for the development of anti-virals therapeutics against SARS-CoV-2. The present work is an approach to design new generation candidate drugs to inhibit SARS-CoV-2 through a molecular modeling approach. For structure-based drug design, molecular docking is a key tool in structural molecular biology and computer-assisted drug design to find the strongest candidate of the drug for various diseases. This technique involves the computational simulation of a ligand, binding to a receptor. To design a biologically active compound lots of money is required, (i) for their synthesis, (ii) to perform the physicochemical/biological characterization of the huge number of molecules, and (iii) to separate the active product from the thousands of synthesized molecules followed by its testing and modification. Therefore, in-silico studies are important to save time and money. Molecular docking predicts the experimental binding modes and affinity of small molecules within the binding site of the particular receptor target which is generally DNA, RNA, or some other biopolymer [1] . In this technique, the 3D structure of a potential ligand (drug) is superimposed on the receptor target site to predict the structure of the intermolecular complexes thus formed. It also forecasts the strength of the binding and the binding affinity between ligand and receptor using scoring functions. If the binding specificity and strength of this protein can be mimicked by a small molecule, then RNA/DNA function can be artificially modulated, by binding this molecule. COVID-19 is a positive sense, single-strand RNA, +ssRNA, associated with nucleoprotein within a capsid comprised of matrix protein and features the largest RNA genome known to date [2, 3] . SARS-CoV-2, SARS-CoV, and MERS-CoV are responsible for severe respiratory illness. The SARS-CoV-2, is of zoonotic origin and a member of the coronviridae genus, specifically of Betacoronavirus based on the nucleotide sequence unlike the MERS-CoV [4, 5, 6, 7, 8] . The spike protein of SARS-CoV-2 is responsible for the attachment at the host cell membrane, where it starts infecting the host [9, 10] . It is reported that the human receptor for COVID-19 is ACE-2/CD26 [11, 12] , and the virus is SARS-CoV-2, a severe acute respiratory syndrome coronavirus. Treatment of COVID-19 is done by many therapeutics including some anti-virals but still, more effective therapeutics are needed especially for patients with co-morbidities [13, 14, 15] . Structures of SARS-CoV-2 and (+)ssRNA [16, 17] , are portrayed in Fig.1. N-Arylhydroxamic acids, the excellent DNA and RNA binders [18 -25] , of the general formula, R 1 -N-OH.R 2 -C=O are neutral, polyfunctional molecules. The pharmacological property of these is associated with their characteristic feature, hydroxamic acid functional group, -N-OH, C=O, which contains both Hydrogen-Bond Donor (HBD) and Hydrogen-Bond Acceptor (HBA) sites [19, 20] . In the present investigation, in-silico docking studies were performed, using AutoDock Vina, to investigate the role of N-arylhydroxamic acids as effective inhibitors of SARS-CoV-2 of COVID-19. The drug-likeness of hydroxamic acids was carried out by Lipinski filter ( http://www.scfbioiitd.res.in/software/drugdesign/lipinski.jsp ), according to which an orally active drug should comply to a minimum of four of the five laid down criteria for drug-likeness. These are molecular mass, H-bond donor and H-bond acceptor sites, lipophilicity, clogP along with molecular refractive index [21] . This rule states that if a molecule has Molecular Weight ≥ 500, Lipophilicity ≥ 5, HBD sites ≥ 5, and HBA sites ≥ 2×5, then a molecule can act as a drug in the biological system and worthy testing for biological assay. All the hydroxamic acids investigated here fulfill this rule. In life sciences, H-bonds are important as they are involved in the most specific molecular interactions of neutral molecules with the receptors and are the weak bonds, rapidly form and break [22, 23] . H-bond interactions play a crucial role in protein-ligand stability and are also an important parameter to determine which amino acid residues are necessary for docking interactions. Lipophilicity of compounds of therapeutic interest is an important parameter to understand the transport process across biological barriers [24] . It is a physicochemical parameter that depends on both, the molecule itself and intermolecular interactions. Collander [25] , proposed that the rate of movement of organic molecules through the cellular material is α to lipophilicity. As per Lipinski [21, 26] , lipophilicity should be less than "5. Substances with high LogP values are so hydrophobic that they partition very poorly into the aqueous components of biological systems. Such compounds remain with the lipid components and are generally poorly absorbed. These are generally bioaccumulated into fat tissue. Compounds with lower LogP do not bioaccumulate because of their low affinity for lipids. Calculated lipophilicity, cLogP, were obtained following the Bio-Loom program of BioByte Company [27, 28, 29] , and the values are presented in Table 1 . Fifteen N-arylhdroxamic acids were chosen as ligands [30, 31, 32, 33, 34] . Their structure and relevant properties are focussed on in Table 1 . The present work is an approach to screen new generation candidate drugs to inhibit SARS- The leading part of targeted bio-macromolecules structure of SARS-CoV-2 Spike glycoprotein holding the heterotrimer chain A, B, and C, and +ssRNA, were downloaded from the PDB database from www.rcsb.org. The crystal structure of the targeted SARS-CoV-2 spike glycoprotein has the PDB ID of 6VSB [36] and +ssRNA has the PDB ID of 6NUD [37] . The targets spike glycoprotein and +ssRNA were optimized for the docking process. All the water molecules and heteroatom were removed and polar hydrogen atoms and charges were added to receptor molecules before initializing the molecular docking process. For the SARS-CoV-2, spike glycoprotein specifically, chain A is mainly kept into the grid as it is the receptor-binding domain. Docking was completed by taking all the rotatable bonds of the complex as rotatable and receptor as rigid. The grid spacing of 1.0 Aͦ with a grid box size of 40×40×40 Aͦ was used that incorporates the active site of SARS-CoV-2 spike glycoprotein and the nucleobases of (+)ssRNA. Default values were taken for other parameters needed for docking. The PDBQT file was generated for the target which was further used for the molecular docking process [38] . 3-D structures of the compounds 1 to 15, were prepared using Marvin Sketch version 16.12.5. The PDB structures were generated with the help of Chem3D Ultra 10.0. Using the MMT algorithm for optimization of the ligands, the lowest energy conformations for further docking were selected. AutoDock Vina is an automated program applied to predict ligand and protein interaction. This software is developed and maintained by Scripps Research Institute [39] . It is open-source molecular modeling software mainly used for protein-ligand docking. It was optimized to use a model containing +ssRNA and different hydroxamic acids that include polar hydrogen atoms, but not the hydrogen atoms bonded to carbon atoms. The AutoDock tool (ADT) file with AutoDock Vina was used for molecular docking, which uses an empirical scoring function based on the free energy of binding [40, 41] . The docking analysis of ligands 1 to 15, which were selected as a ligand with SARS-CoV-2 spike glycoprotein and +ssRNA were carried out. The Lamarckian Genetic Algorithm (LGA) was used among the AutoDock suite. Employing the MGL Tool 1.5.6. and PyMOL 2.3.4.; the analysis of docking results and binding sites was performed, respectively. Various interactions like hydrogen bonding, hydrophobic interactions, π -π stacking, and halogen bonding along with the distance between the ligand and target were analyzed thoroughly. In computational chemistry and molecular modeling, scoring functions are mathematical functions used to predict the binding affinity between two molecules after they have been Docking predicted the experimental binding modes and affinity of small molecules with the binding sites of the particular receptor target. In the present study, spike glycoprotein is used The detailed interaction profile of the most potent ligand, N-phenyl-naphtho hydroxamic acid, ligand 9 is explored in Figure 2 . The docked structures of other ligands in the binding pocket of spike protein residues, hydrogen-bond distance, interactions exhibited, and π-π stacking are presented in Fig 3. The binding energies are depicted in Table 2 and details of all ligands, including predicted key residues involved in the interactions, distance between interacting residues, and ligand atom are portrayed in Table S1 . Hydrogen bonds are depicted in blue color and hydrophobic interactions are shown in grey-colored dashes and π-π stacking is portrayed in green-colored dashes with white balls in aromatic rings. Binding Energy (kcal/mol) S.No . Overall results demonstrate that all the N-arylhydroxamic acids interact with the +ssRNA base. The binding energies are tabulated in Table 2 . The best molecular docked structure for ligand-9, N-phenyl-naphthohydroxamic acid is presented in Fig. 4 , and all other ligands with the target are demonstrated in Fig 5. The interacting bases with the ligand atom and the distance between them along with the type of interactions are summarized in Table S2 . In comparison to all the hydroxamic acids, both of the naphthyl derivatives possess the lowest binding energy of -6.1 Kcal/mol and the highest binding affinity towards a singlestrand of (+)ssRNA. The above observations suggest that N-arylhydroxamic acids are wonderful ligands interacting with +ssRNA effectively and can be further used as therapeutic agents against the +ssRNA genome of COVID-19. Docking is a molecular modeling technique that is used to predict how a protein interacts with the ligand. The present investigation shed a light on the potential interactions between hydroxamic acids and SARS-CoV-2 indicating the involvement of multiple interactions such as H-bonds, hydrophobic interactions, van der Waals forces, π stacking and halogen bonds, mostly depending on the binding sites of SARS-CoV-2 and the ligands. All ligands show better binding strength to SARS-CoV-2 and thus hold a promising potential to be explored for their anti-SARS-CoV-2 activity. These are worth further investigations in terms of both in-vitro and in-vivo studies. Based on docking scores it is concluded that all the hydroxamic acids display a better binding strength to SARS-CoV-2. Structure of the RNAdependent RNA polymerase from COVID-19 virus Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS like disease Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses COVID-19 spike-host cell receptor GRP78 binding site prediction The Importance of Research on the Origin of SARS-CoV-2, Viruses Questions concerning the proximal origin of SARS-CoV-2 Recent Discovery and Development of Inhibitors Targeting Coronaviruses Insights From Nanomedicine Into Chloroquine Efficacy Against COVID-19 Comparative Genetic Analysis of the Novel Corona Virus Receptor ACE2 in Different Populations Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics Structure-Based Stabilization of Non-native Protein−Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design The structural basis of accelerated host cell entry by SARS-CoV-2 Mechanism of Apoptotic Death in Ehrlich Ascites Tumor Cells Induced by Derivatives of Hydroxamic Acids acid Hydroxamic Acids in Nature Hydroxamic acids: proton donor and acceptor strength for use in drug design Lead and Drug like compounds, the rule-of-five revolution 09 -Structural, Energetic, and Dynamic Aspects of Ligand-Receptor Interactions Molecular Descriptors of N-Arylhydroxamic Acids: A Tool in Drug Design Lipophilicity in Drug Discovery The Partition of Organic Compounds Between Higher Alcohols and Water Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings Calculating log POa From Structures Determination of the Lipophilicity of Quinolinesulfonamides by Reversed-Phase HPLC and Theoretical Calculations Preparation and Properties of Some N-Aryl Hydroxamic Acids Synthesis of N-Arylhydroxamic Acids Preparation and Properties of N-Methyl-and N-(4-Chlorophenyl)-Substituted Hydroxamic Acids Studies on Hydroxamic Acids: Preparation and Properties of N-1-Naphthylhydroxamic Acids Preparation and Properties of N-Arylhydroxamic Acids Software For Molecular Docking: a Review Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation Coupling of +ssRNA Cleavage with DNase Activity in Type III-A CRISPR-Csm Revealed by Cryo-EM and Biochemistry Ultra-fast FFT Protein Docking on Graphics Processors AutoDock Vina: Improving the Speed and Accuracy of Docking With a New Scoring Function, Efficient Optimization, and Multithreading A Semiempirical Free Energy Force Field with Charge-based Desolvation How Paramagnetic and Diamagnetic LMOCs Detect Picric Acid From Surface Water and the Intracellular Environment: A Combined Experimental and DFT-D3 study PLIP: fully automated protein-ligand interaction profiler Evaluation of Lipophilicity of N-Arylhydroxamic acids by Reversed Phase-high Performance Liquid Chromatographic Method and Self-organizing Molecular Field Analysis Evaluation of Antioxidant Activity and DNA Cleavage Protection Effect of Naphthylhydroxamic Acid Derivatives Through Conventional and Fluorescence Microscopic Methods, Chemical Paper Determination of Volumetric, Steric and Excess Properties of Naphthylhydroxamic Acid Derivatives in Ethanol At 298.15 and 313.15 K The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings This research did not receive any financial support from funding agencies in the public, commercial, or not for -profit sectors. The authors declared no conflict of interest. Dr. Yamini Thakur:The main experimental work and writing of the manuscript. The analysis of the results, conceptualization, methodology. The approach of the research, formal analysis, data curation, writing-review and editing. Supervision of the experimental work and analysis of the information.  ☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:The authors declare no competing financial interests.